IFNA17 and systemic lupus erythematosus: To test this hypothesis, we re-analyzed a series of 32 SLE samples in which the proportion of samples showing extremely low IFNα17/α2 ratios was increased in an assay buffer (Buffer B, Quanterix) specifically developed for low background.